JP2008531701A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531701A5
JP2008531701A5 JP2007558123A JP2007558123A JP2008531701A5 JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5 JP 2007558123 A JP2007558123 A JP 2007558123A JP 2007558123 A JP2007558123 A JP 2007558123A JP 2008531701 A5 JP2008531701 A5 JP 2008531701A5
Authority
JP
Japan
Prior art keywords
compound
amino
pharmaceutically acceptable
combination
sugar moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/007021 external-priority patent/WO2006093933A2/en
Publication of JP2008531701A publication Critical patent/JP2008531701A/ja
Publication of JP2008531701A5 publication Critical patent/JP2008531701A5/ja
Pending legal-status Critical Current

Links

JP2007558123A 2005-02-28 2006-02-27 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド Pending JP2008531701A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65763605P 2005-02-28 2005-02-28
PCT/US2006/007021 WO2006093933A2 (en) 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009035654A Division JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Publications (2)

Publication Number Publication Date
JP2008531701A JP2008531701A (ja) 2008-08-14
JP2008531701A5 true JP2008531701A5 (enExample) 2009-04-09

Family

ID=36941722

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558123A Pending JP2008531701A (ja) 2005-02-28 2006-02-27 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド
JP2009035654A Pending JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009035654A Pending JP2009102445A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成転位バンコマイシン/デスメチル−バンコマイシンベースのグリコペプチド

Country Status (7)

Country Link
US (2) US7368422B2 (enExample)
EP (1) EP1858908A4 (enExample)
JP (2) JP2008531701A (enExample)
AU (1) AU2006218743A1 (enExample)
BR (1) BRPI0607701A2 (enExample)
CA (1) CA2599336A1 (enExample)
WO (1) WO2006093933A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1818340A4 (en) 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp ANTIBIOTIC MONOMERS GLYCOPEPTIDE DERIVATIVES
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
KR20100109936A (ko) * 2007-12-26 2010-10-11 리드 테라퓨틱스, 인크. 항박테리아제로서의 신규한 반(半)-합성 글리코펩티드
WO2010048340A2 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
WO2011060222A2 (en) * 2009-11-13 2011-05-19 Beckman Coulter, Inc. Systems and methods for detecting the presence of a biological status using clustering

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692327A (en) * 1984-09-06 1987-09-08 Fujimori Kogyo Co., Inc. Laminated film for packaging
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) * 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
BRPI9914221B8 (pt) * 1998-12-23 2021-05-25 Advanced Medicine Inc derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
US6498238B1 (en) * 1999-05-19 2002-12-24 Princeton University Glycopeptide antibacterial compounds, compositions containing same and methods of using same
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) * 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
KR20060091049A (ko) 2002-08-30 2006-08-17 케이.유.루벤 리서치 앤드 디벨럽먼트 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용
AU2003287605A1 (en) * 2002-11-12 2004-06-03 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity

Similar Documents

Publication Publication Date Title
WO2007138110A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
JP2009504764A5 (enExample)
JP2008510770A5 (enExample)
JP2011526924A5 (enExample)
JP2007522220A5 (enExample)
JP2006526031A5 (enExample)
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
JP2009502743A5 (enExample)
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
PT2322525E (pt) Derivados de purina para utilização como agonistas do recetor de adenosina a2a
JP2006514012A5 (enExample)
JP2010515731A5 (enExample)
WO2010026436A3 (en) 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
JP2009511508A5 (enExample)
JP2013514980A5 (enExample)
JP2011507896A5 (enExample)
JP2008531701A5 (enExample)
JP2009520695A5 (enExample)
EP2145877A3 (en) Aurora Kinase inhibitors
JP2007500222A5 (enExample)
JP2008531702A5 (enExample)
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
JP2010514734A5 (enExample)
JP6293736B2 (ja) 細菌感染症を治療するための方法および組成物